Connect

To receive new posts automatically via e-mail, enter your address:

Delivered by FeedBurner


June 1st, 2012

Diabetes Drug Maker Fights Pay-to-Play in Once-and-Future Judicial Hellhole

Standing up to Louisiana’s attorney general and his personal injury lawyer pals, the maker of a widely prescribed treatment for Type 2 diabetes yesterday sought to end what it calls an unlawful fee arrangement in connection with the AG’s multibillion-dollar lawsuit against it.

GlaxoSmithKline LLC (GSK) makes Avandia, the diabetes drug that Attorney General James . . . → Read More: Diabetes Drug Maker Fights Pay-to-Play in Once-and-Future Judicial Hellhole